OQROGet OQRO Pro
Insider trade

ResMed| (RMD)Director sold ~$498K

Peter C Farrell, Director at ResMed|, sold ~$498K of ResMed| shares.

~$498K
Approx. value · 2,000 sh @ $248.83
67K
Holds after · shares reported
Traded
Jan 7, 2026
Filed
Jan 9, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 7, 2025InsiderCEO sold ~$2M of RMD shares in the open market
  2. Nov 11, 2025InsiderDirector sold ~$122K of RMD shares in the open market
  3. Nov 12, 2025InsiderDirector sold ~$504K of RMD shares in the open market
  4. Nov 19, 2025Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On November 19, 2025, our board of directors approved reducing the number of directors serving on our board from twelve (12) to eleven (11).”
  5. Nov 25, 2025InsiderDirector sold ~$524K of RMD shares in the open market
  6. Dec 1, 2025Insider · 2 peopleInsiders: 2 sales (~$256K)
  7. Dec 3, 2025InsiderDirector sold ~$503K of RMD shares in the open market
  8. Dec 5, 2025FDAFDA device clearance: Personalized Therapy Comfort Settings (PTCS)
  9. Dec 8, 2025InsiderCEO sold ~$1.25M of RMD shares in the open market
  10. Jan 2, 2026Insider · 2 peopleInsiders: 2 sales (~$254K)
  11. Jan 7, 2026 · this disclosureInsiderDirector sold ~$498K of RMD shares in the open market

What came next

  1. Jan 7, 2026InsiderCEO sold ~$1.24M of RMD shares in the open market
  2. Jan 29, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  3. Feb 2, 2026InsiderCFO sold ~$257K of RMD shares in the open market
  4. Feb 4, 2026Insider · 2 peopleInsiders: 2 sales (~$516K)
  5. Feb 9, 2026InsiderCEO sold ~$1.37M of RMD shares in the open market
  6. Feb 23, 2026FDAFDA device clearance: Mariana Minerva; Mariana Nimbus
  7. Mar 2, 2026InsiderCFO sold ~$254K of RMD shares in the open market
  8. Mar 4, 2026InsiderDirector sold ~$520K of RMD shares in the open market
  9. Mar 9, 2026InsiderCEO sold ~$1.25M of RMD shares in the open market
  10. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  11. Apr 1, 2026Insider · 2 peopleInsiders: 2 sales (~$674K)
  12. Apr 7, 2026InsiderCEO sold ~$1.13M of RMD shares in the open market
  13. Apr 8, 2026FDAFDA device clearance: myAir
  14. Apr 24, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 30, 2026, ResMed Inc. (the “Company”) announced that Brett Sandercock, Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, will retire from his role as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer.”
  15. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 8.2%
  16. Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.4%
  17. Apr 30, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for ResMed|

For ResMed|, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 19 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RMD page.

Other recent filings by Peter C Farrell, Director

The full history of Peter C Farrell, Director is on the profile page.

How this filing works

Other disclosures at ResMed|

Everything OQRO holds on this company is on its RMD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data